Biomarkers are now the currency of precision medicine and preventive health. Choose the partner that matches your goals, whether that is advancing a clinical trial, validating a new drug, or extending ...
The EV-302 study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS), compared to chemotherapy. An Independent Data Monitoring Committee determined that OS ...
Pioneering study aims to demonstrate the robustness of personalized medication analysis and recommendations for polypharmacy patients generated by MDI Health’s novel Artificial Pharmacology ...
Healthcare apps are gaining more popularity every year, and 2023 will be no exception. Discover the possibilities you can find in developing healthcare applications and the steps you need to take to ...
Avania will evolve, invest, and pivot with the industry so it can achieve its mission of partnering with MedTech sponsors to bring life-changing technology to market, resulting in improved healthcare ...
Former Pfizer Chief Scientific Officer Dr. Mikael Dolsten, Joins MC Sciences as Independent Chairman
In this role, Dr. Mikael Dolsten will help advance the company's mission of developing transformative and superior therapeutics targeting and controlling mast cells across multiple high-need disease ...
Data from the Rotterdam Study in the Netherlands. Using data from the Rotterdam Study in the Netherlands, researchers have uncovered that carotid artery plaques can undergo potentially dangerous ...
Under the agreement, NAMSA will acquire WuXi AppTec facilities in Minnesota and Georgia. NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that it has ...
The ready-to-use test integrates two previously FDA-cleared indicators – a biological indicator for confirming microbial neutralization and a chemical indicator for verifying proper sterilizer ...
In this pivotal role, Dr. Wright will lead MolecuLight's global medical and clinical strategy. MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced ...
"We designed the IntelAir™ to fulfill a market need; while some devices focused on patient needs and others on clinician needs, none appropriately served both. With this all-in-one device, users can ...
RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first, automated 3D imaging ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback